GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Remedium Lifecare Ltd (BOM:539561) » Definitions » EBIT

Remedium Lifecare (BOM:539561) EBIT : ₹443 Mil (TTM As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Remedium Lifecare EBIT?

Remedium Lifecare's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was ₹53 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹443 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Remedium Lifecare's annualized ROC % for the quarter that ended in Sep. 2024 was 1.00%. Remedium Lifecare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 76,112.64%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Remedium Lifecare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 11.40%.


Remedium Lifecare EBIT Historical Data

The historical data trend for Remedium Lifecare's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remedium Lifecare EBIT Chart

Remedium Lifecare Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.82 6.64 17.02 74.68 544.78

Remedium Lifecare Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 104.05 688.03 -319.98 22.67 52.71

Competitive Comparison of Remedium Lifecare's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Remedium Lifecare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Remedium Lifecare's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Remedium Lifecare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Remedium Lifecare's EV-to-EBIT falls into.



Remedium Lifecare EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹443 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Remedium Lifecare  (BOM:539561) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Remedium Lifecare's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=177.936 * ( 1 - 27.82% )/( (0 + 12789.128)/ 1 )
=128.4342048/12789.128
=1.00 %

where

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=21517.189 - 8676.928 - ( 51.133 - max(0, 21058.203 - 21516.646+51.133))
=12789.128

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Remedium Lifecare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=210.832/( ( (0 + max(0, 0)) + (0.277 + max(-6389.92, 0)) )/ 1 )
=210.832/( ( 0 + 0.277 )/ 1 )
=210.832/0.277
=76,112.64 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(9788.05 + 3037.705 + 27.894999999997) - (8676.928 + 0 + 10566.642)
=-6389.92

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Remedium Lifecare's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=443.426/3888.364
=11.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Remedium Lifecare EBIT Related Terms

Thank you for viewing the detailed overview of Remedium Lifecare's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Remedium Lifecare Business Description

Traded in Other Exchanges
N/A
Address
Saugbaug Road, Office No. 9, Behind Ravi Vihar Hotel, K Raheja Prime, Marol Industrial Estate, Andheri (East), Mumbai, MH, IND, 400059
Remedium Lifecare Ltd is engaged in the business of trading in API Intermediates (KSMs & CRMs) and various other raw materials used in API trading viz. Iso propyl Alcohol (IPA), Cyclohexane, DI Iso Propyl Amine (DIPA), Ethyl Acetate, Hydrazine Hydrate, Iso propyl Alcohol (IPA), Methylene Di Chloride, Potassium Carbonate Powder, Sodium Bi-Carbonate, Potassium Hydroxide Flakes, Sodium Chloride (Common Salt), Sodium Carbonate (SODA ASH), Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide (TMSI).

Remedium Lifecare Headlines

No Headlines